Dentures Biofilm and Artificial Biofilm Substitute (KÜBI)

December 2, 2021 updated by: Technische Universität Dresden

Polysaccharide-based, Artificial Biofilm Substitute - Clinical Pilot Study for Validation Process

The biofilm on oral surfaces can lead to oral diseases. The correlation between oral biofilm and diseases and general health is well known. Therefore, cleaning of teeth or dentures from biofilm is essential for the maintenance of oral and general health. Currently, the society is ageing, the number of elderly as well as home and institutionalized care patients is increasing. In particular, these suffer from higher tooth loss, wear removable dentures and have problems with independent oral and denture hygiene. Therefore, support from well-trained nursing staff or family members is important. The use of suitable artificial biofilm substitutes may be helpful, in order to efficiently and easily perform oral and denture hygiene education, as well as to carry out laboratory tests of oral and denture hygiene products. The absence of such appropriate substitutes for denture biofilm requires innovations in this field. The aim of this pilot study is to verify the feasibility of the study protocol, design and methods. Additionally, an innovative artificial biofilm substitute based on polysaccharides will be further developed. This pilot study includes five study parts. Two in vivo examinations and three in vitro tests. This pilot study creates the basis for further main studies and implements the development of validated artificial biofilm substitutes.

Study Overview

Detailed Description

The bacterial biofilm on the intraoral surfaces is a three-dimensionally structured, firmly adhering layer of microorganisms surrounded by a matrix of extracellular polymeric substances (EPS). This matrix can take up to 90% of the biofilm mass. Biofilm on oral surfaces can lead to diseases such as caries, periodontitis or denture stomatitis. Furthermore, an association between denture biofilm, which serves as a reservoir for various bacteria, and general diseases is described. Adequate denture hygiene is therefore essential for maintaining the health of denture wearers. Nevertheless, adequate oral and denture hygiene is not sufficiently available for many, especially institutionalized elderly. The reasons are mostly insufficient preventive measures to train denture wearers, nursing staff and family members, as well as a lack of training materials such as dentures with artificial biofilm equivalents, which have the same cleaning properties as real dentures biofilm.

The absence of such appropriate substitutes for denture biofilm requires innovations in this field. Further, clinical data for validation of innovative artificial biofilm substitutes are missing.

The aim of this pilot study is to carry out preliminary tests for the development of a polysaccharide-based artificial biofilm substitute to simulate the real denture biofilm and to verify the feasibility of the study protocol, design and methods i.e. recording the obligatory manual and mechanical brushing cycles or for adapting the mechanical properties and adhesive strength to the clinically recorded data.

This pilot study includes 2 in vivo and 3 in vitro parts. The in vivo examinations contain 8 visits for participants. For biofilm formation participants omit cleaning dentures for 12 and 36 hours. Biofilm formation occurs between the visits and removal within the visits. Digital planimetry will be performed to measure the biofilm formation and removal. Within 3 in vitro tests, the mechanical properties of the artificial biofilm substitutes will be adjusted and the reliability tested. The artificial biofilm contains chitosan and methylcellulose. The mechanical brushing cycles needed to remove artificial biofilm substitutes, will be measured by a tooth-brushing simulator under standardized conditions. Digital planimetry of artificial biofilm after brushing will be performed.

The collected data will be used for further conceptualization of the main study.

Study Type

Interventional

Enrollment (Actual)

8

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Saxony
      • Dresden, Saxony, Germany, 01307
        • Department of Prosthetic Dentistry, Carl Gustav Carus Faculty of Medicine, TU Dresden

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Individuals 18 years of age or older
  • Individuals wearing sufficient acrylic resin (PMMA) complete upper or complete upper and lower denture
  • healthy oral mucosa
  • written informed consent

Exclusion Criteria:

  • Individuals who have severe systemic and/or infectious diseases
  • Female individuals who are pregnant or breastfeeding
  • allergies or hypersensitivity to the used products and/or materials
  • smokers
  • Individuals with a history of chronic drug abuse or another illness which does not allow the participant to assess the nature and/or possible consequences of the study
  • inability to comply with study protocol requirements
  • Individuals who have participated in another clinical study less than 4 weeks prior to the baseline examination

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Other
  • Allocation: N/A
  • Interventional Model: Single Group Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Other: Biofilm formation
Biofilm formation after 12 and 36 h on PMMA (polymethyl methacrylate) dentures and the number of brushing cycles needed to remove it.

Capturing the clinical data for biofilm formation on PMMA dentures and samples worn by participants and the number of brushing cycles required to remove this biofilm.

Development of artificial denture biofilm substitute with similar mechanical properties to real denture biofilm.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
dentures brushing cycles 12 h in vivo
Time Frame: 2 days
Capturing the data for the number of brushing cycles needed to remove artificial biofilm from dentures worn by participants for 12h.
2 days
brushing cycles in vitro
Time Frame: 4 months
Capturing the data for the number of brushing cycles needed to remove artificial biofilm from dentures or samples.
4 months

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
percentage of plaque (POP)
Time Frame: 3 - 12 weeks
Measuring of denture area covered with biofilm by digital planimetry.
3 - 12 weeks
dentures brushing cycles 36 h in vivo
Time Frame: 4 days
Capturing the data for the number of brushing cycles needed to remove artificial biofilm from dentures worn by participants for 36 h.
4 days
samples brushing cycles 12 h in vivo
Time Frame: 2 days
Capturing the data for the number of brushing cycles needed to remove artificial biofilm from samples worn by participants for 12h.
2 days
samples brushing cycles 36 h in vivo
Time Frame: 4 days
Capturing the data for the number of brushing cycles needed to remove artificial biofilm from samples worn by participants for 36 h.
4 days

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Study Chair: Katarzyna Walczak, Dr.med.dent., Department of Prosthetik Dentistry, Faculty of Medicine, TU Dresden

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

March 2, 2020

Primary Completion (Actual)

December 31, 2020

Study Completion (Actual)

December 31, 2020

Study Registration Dates

First Submitted

January 13, 2020

First Submitted That Met QC Criteria

January 27, 2020

First Posted (Actual)

January 30, 2020

Study Record Updates

Last Update Posted (Actual)

December 3, 2021

Last Update Submitted That Met QC Criteria

December 2, 2021

Last Verified

December 1, 2021

More Information

Terms related to this study

Other Study ID Numbers

  • TUDKW20200115
  • 427547277 (Other Grant/Funding Number: German Research Foundation (DFG))

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

No

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Biofilm

Subscribe